Loading
Latest filing published 29 Nov 2019 for NervGen Pharma Corp..
No signal scores available.
Only one filing by Lloyd Mackenzie is known so far (29 November 2019): a transaction, in NervGen Pharma Corp. That is too little to draw conclusions. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.